Ruha Cherian is a Health Economic Modeller at Eli Lilly and Company, where their work supports country-specific adaptations across Diabetes, Obesity, Oncology, and Immunology therapy areas. They are currently contributing to the development of global models, including the Tirzepatide (Mounjaro) initiative. Ruha holds a Bachelor of Arts in Economics from St. Xavier's College and has a Master's in Applied Economics. They also have past experience as a School Social Worker and completed an internship with The Times of India.
This person is not in the org chart
This person is not in any teams
This person is not in any offices